SlideShare ist ein Scribd-Unternehmen logo
1 von 18
Paired and AltruisticPaired and Altruistic
Kidney Donation InKidney Donation In
The UKThe UK
Deborah Green
North Bristol Academy
ObjectivesObjectives
 Why this topic?
 Paired donation
 The process
 UK programme and problems
 Altruistic donation
 Definition and development
 Programmes worldwide
 Patient views
Kidney DonationKidney Donation
 Types: DECEASED
LIVE
 Problems
1. ABO incompatibility
2. Presence of donor-specific
HLA antibodies
Paired DonationPaired Donation
Scheme run by BTS and UKT since 2007
DONOR 1 RECIPIENT 1
DONOR 2 RECIPIENT 2
The Matching ProcessThe Matching Process
Quarterly matching runs
Three stages:
Identify all possible two-way exchanges
Determine all combinations of exchange
Identify optimum combinations
Identifying Optimum Transplant NumberIdentifying Optimum Transplant Number
Criteria Points
Location of pairs •Same area - 20
•Otherwise - 0
HLA Match •Level 1 – 15
•Level 4 – 0
Sensitisation •0 – 50 points
Donor – donor age
difference
•< 20 years – 3 points
•> 20 years – 0 points
Blood group matching •O donors reserved for O
recipients
UK Programme Jan 2007 – Jan 2011UK Programme Jan 2007 – Jan 2011
465 patients enrolled
198 transplants identified
51% of identified transplants have not
taken place
Outcome of Identified TransplantsOutcome of Identified Transplants
0
5
10
15
20
25
30
35
40
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Not proceeding
Transplant
No. of
potential
transplants
Matching runApr 2007 Jan 2011
(Data from UKT)
Non-Proceeding TransplantsNon-Proceeding Transplants
Pos XM
38%
Alternative
transplant
20%
Donor or recipient
unfit
24%
Other
18%
(Data from UKT)
ExplanationsExplanations
Large proportion of highly sensitised
patients in UK cohort
◦ 97% UK
◦ 41% The Netherlands
(Johnson et al 2008)
Blood type skewing
◦ 50% of pairs with blood type O recipients
◦ 30% of pairs with blood type O donors
(15% match rate for O recipients currently)
(Johnson et al 2008)
SolutionsSolutions
1.Allowing compatible pairs to join the
paired scheme
• Simulation studies show up to 75%
increase in match rate for O recipients
(Gentry et al. 2007)
2.Combining desensitisation with paired
donation
• Complimentary modalities in the US for
difficult to match patients. (Segev et al. 2008)
Altruistic DonationAltruistic Donation
Individual live donors with no genetic or
personal link to a recipient.
60 altruistic donations in the UK to date
Altruistic DonationAltruistic Donation
0
200
400
600
800
1000
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Altruistic donor (non-directed)
Paired exchange donor
ABO incompatible donor
HLA incompatible donor
Unrelated donor (directed)
Related donor
(Data from UKT)
Tx N◦
Year
Where Do They Fit in?Where Do They Fit in?
Donate to a recipient high on the
deceased waiting list
Donate to the paired donor scheme
◦ Transplant numbers increased 1.6 times per
altruistic donor
(Roodnat et al 2010)
Domino-Paired DonationDomino-Paired Donation
• Two transplants take place
ReflectionReflection
 Potential for the paired scheme to help many
unmatched patients
 Making best use of altruistic donors
 MDT involvement at many levels
 Impact on lives of patients
What the patients say...What the patients say...
‘...I was on dialysis for 5 years
before they finally found a
match. I just wanted to die in my
sleep...’
‘ You feel so helpless. He was so ill
and I wasnt able to do anything but
wait...’
Any Questions?
ReferencesReferences
 Gentry SE, Montgomery RA, Segev DL. Kidney Paired Donation: Fundamentals, Limitations and Expansions.
American Journal of Kidney Diseases. 2011; 57(1): 144-151
 Johnson RJ, Allen JE, Fuggle SV, Bradley JA, Rudge C. Early Experience of Paired Living Kidney Donation In The
UK. Transplantation. 2008; 86(12): 1672-1677
 Mongomery RA, Renal Transplantation Across HLA and ABO Antibody Barriers: Integrated Paired Donation
Into Desensitisation Protocols. American Journal of Transplantation. 2010; 10: 449-457
 Rapaport FT. The case for a living emotionally related international kidney donor exchange registry.
Transplant Proc. 1986; 18: 5
 Kwak JY, Kwon OJ, Lee KS et al. Exchange-donor program in renal transplantation: A single centre experience.
Transplant Proc. 1999; 31: 344
 Johnson RJ et al. Paired and Altruistic Non-Directed Living Kidney Donation. Renal Transplant Services Meeting
January 2011. Accessed March 2011
 Segev DL, Kucirka LM, Gentry SF, Montgomery RA. Utilisation And Outcomes Of Kidney Paired Donation In
the US. Transplantation. 2008; 86: 502-510
 Gentry SE, Segev DL, Simmerling M, Mongomery RA. Expanding Kidney Paired Donation Through Participation
By Compatible Pairs. American Journal of Transplantation. 2007; 7: 2361-2370
 Gentry SE, Montgomery RA, Swihart BJ, Segev DL. The roles of dominos and never-ending altruistic donor
chains in kidney paired donation. American Journal of Transplantation. 2009; 9: 1330-1336
 The National Matching Scheme For Paired Donation. Available at www.bts.org.uk. Accessed March 2011
 UK Transplant. Available at www.uktransplant.org.uk. Accessed February 2011

Weitere ähnliche Inhalte

Was ist angesagt?

Renal Replacement therapy in the ICU
Renal Replacement therapy in the ICU Renal Replacement therapy in the ICU
Renal Replacement therapy in the ICU Syed Hussain
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Hepatitis C in kidney transplantation
Hepatitis C in kidney transplantationHepatitis C in kidney transplantation
Hepatitis C in kidney transplantationSalwa Ibrahim
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Gastrocon 2016 - Hepatorenal Syndrome
Gastrocon 2016 - Hepatorenal SyndromeGastrocon 2016 - Hepatorenal Syndrome
Gastrocon 2016 - Hepatorenal SyndromeApolloGleaneagls
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadNephroTube - Dr.Gawad
 
Hepatitis B in Dialysis and Transplantation
Hepatitis B in Dialysis and TransplantationHepatitis B in Dialysis and Transplantation
Hepatitis B in Dialysis and TransplantationSandeep Gopinath Huilgol
 
Causes of hypotension during dialysis by aniqa atta
Causes of hypotension during dialysis by aniqa attaCauses of hypotension during dialysis by aniqa atta
Causes of hypotension during dialysis by aniqa attaaniqaatta1
 
Evaluation of kidney donor
Evaluation of kidney donorEvaluation of kidney donor
Evaluation of kidney donorFarragBahbah
 
Dng hbv -kidney disease
Dng  hbv -kidney  diseaseDng  hbv -kidney  disease
Dng hbv -kidney diseaseFarragBahbah
 
Renal replacement therapy in the ICU
Renal replacement therapy in the ICURenal replacement therapy in the ICU
Renal replacement therapy in the ICUmeducationdotnet
 
Crossmatch strategies in renal transplantation
Crossmatch strategies in renal transplantationCrossmatch strategies in renal transplantation
Crossmatch strategies in renal transplantationscienthiasanjeevani1
 
Theraputic apharesis in renal disorders dr.yasser abd elhmed
Theraputic apharesis in renal disorders dr.yasser abd elhmedTheraputic apharesis in renal disorders dr.yasser abd elhmed
Theraputic apharesis in renal disorders dr.yasser abd elhmedFarragBahbah
 
Dr hesham elsayed hd adequacy and dose optimization
Dr hesham elsayed   hd adequacy and dose optimizationDr hesham elsayed   hd adequacy and dose optimization
Dr hesham elsayed hd adequacy and dose optimizationFarragBahbah
 
Rrt in icu dr said khamis zagazig april 2018 latest
Rrt in  icu dr said khamis zagazig april 2018 latestRrt in  icu dr said khamis zagazig april 2018 latest
Rrt in icu dr said khamis zagazig april 2018 latestFarragBahbah
 
New aphresis prof ehab wafa
New aphresis prof ehab wafaNew aphresis prof ehab wafa
New aphresis prof ehab wafaFarragBahbah
 
Dialysis dose prescription (the basics) dr ujjawal
Dialysis dose prescription (the basics) dr ujjawalDialysis dose prescription (the basics) dr ujjawal
Dialysis dose prescription (the basics) dr ujjawalUjjawal Roy
 

Was ist angesagt? (20)

Renal Replacement therapy in the ICU
Renal Replacement therapy in the ICU Renal Replacement therapy in the ICU
Renal Replacement therapy in the ICU
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Hepatitis C in kidney transplantation
Hepatitis C in kidney transplantationHepatitis C in kidney transplantation
Hepatitis C in kidney transplantation
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Gastrocon 2016 - Hepatorenal Syndrome
Gastrocon 2016 - Hepatorenal SyndromeGastrocon 2016 - Hepatorenal Syndrome
Gastrocon 2016 - Hepatorenal Syndrome
 
Incremental Dialysis
Incremental DialysisIncremental Dialysis
Incremental Dialysis
 
Dose of hd
Dose of hdDose of hd
Dose of hd
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
 
Hepatitis B in Dialysis and Transplantation
Hepatitis B in Dialysis and TransplantationHepatitis B in Dialysis and Transplantation
Hepatitis B in Dialysis and Transplantation
 
Causes of hypotension during dialysis by aniqa atta
Causes of hypotension during dialysis by aniqa attaCauses of hypotension during dialysis by aniqa atta
Causes of hypotension during dialysis by aniqa atta
 
Evaluation of kidney donor
Evaluation of kidney donorEvaluation of kidney donor
Evaluation of kidney donor
 
Dng hbv -kidney disease
Dng  hbv -kidney  diseaseDng  hbv -kidney  disease
Dng hbv -kidney disease
 
Renal replacement therapy in the ICU
Renal replacement therapy in the ICURenal replacement therapy in the ICU
Renal replacement therapy in the ICU
 
Hemodialysis Adequacy
Hemodialysis AdequacyHemodialysis Adequacy
Hemodialysis Adequacy
 
Crossmatch strategies in renal transplantation
Crossmatch strategies in renal transplantationCrossmatch strategies in renal transplantation
Crossmatch strategies in renal transplantation
 
Theraputic apharesis in renal disorders dr.yasser abd elhmed
Theraputic apharesis in renal disorders dr.yasser abd elhmedTheraputic apharesis in renal disorders dr.yasser abd elhmed
Theraputic apharesis in renal disorders dr.yasser abd elhmed
 
Dr hesham elsayed hd adequacy and dose optimization
Dr hesham elsayed   hd adequacy and dose optimizationDr hesham elsayed   hd adequacy and dose optimization
Dr hesham elsayed hd adequacy and dose optimization
 
Rrt in icu dr said khamis zagazig april 2018 latest
Rrt in  icu dr said khamis zagazig april 2018 latestRrt in  icu dr said khamis zagazig april 2018 latest
Rrt in icu dr said khamis zagazig april 2018 latest
 
New aphresis prof ehab wafa
New aphresis prof ehab wafaNew aphresis prof ehab wafa
New aphresis prof ehab wafa
 
Dialysis dose prescription (the basics) dr ujjawal
Dialysis dose prescription (the basics) dr ujjawalDialysis dose prescription (the basics) dr ujjawal
Dialysis dose prescription (the basics) dr ujjawal
 

Ähnlich wie Paired and Altruistic Kidney Donation In The UK

Gabriel Danovitch - USA - Monday 28 - Alternatives to increase the number of...
Gabriel Danovitch - USA  - Monday 28 - Alternatives to increase the number of...Gabriel Danovitch - USA  - Monday 28 - Alternatives to increase the number of...
Gabriel Danovitch - USA - Monday 28 - Alternatives to increase the number of...incucai_isodp
 
Intensive Care Professionals and their role in Organ Donation
Intensive Care Professionals and  their role in Organ DonationIntensive Care Professionals and  their role in Organ Donation
Intensive Care Professionals and their role in Organ DonationStiftelsen Organdonasjon
 
Preliminary Research Data
Preliminary Research DataPreliminary Research Data
Preliminary Research Datalaurenkriley
 
Faith and BAME on Organ Donation in UK
Faith and BAME  on Organ Donation in UKFaith and BAME  on Organ Donation in UK
Faith and BAME on Organ Donation in UKDr Shibu Chacko MBE
 
Kidney Transplant Exploring Living Donation
Kidney Transplant Exploring Living DonationKidney Transplant Exploring Living Donation
Kidney Transplant Exploring Living DonationDebra Fette
 
Marginal and extended criteria donors
Marginal and extended criteria donorsMarginal and extended criteria donors
Marginal and extended criteria donorsDr. Rohit Saini
 
Marginal Donors/Expanded Criteria Donors Kidneys
Marginal Donors/Expanded Criteria Donors KidneysMarginal Donors/Expanded Criteria Donors Kidneys
Marginal Donors/Expanded Criteria Donors KidneysAbdullah Ansari
 
Anwar Naqvi Pakistan - Monday 28 - Management and organization models for d...
Anwar Naqvi   Pakistan - Monday 28 - Management and organization models for d...Anwar Naqvi   Pakistan - Monday 28 - Management and organization models for d...
Anwar Naqvi Pakistan - Monday 28 - Management and organization models for d...incucai_isodp
 
Jonathan G Stine, Puja M Shah, Scott L Cornella, Sean R Rudnic.docx
Jonathan G Stine, Puja M Shah, Scott L Cornella, Sean R Rudnic.docxJonathan G Stine, Puja M Shah, Scott L Cornella, Sean R Rudnic.docx
Jonathan G Stine, Puja M Shah, Scott L Cornella, Sean R Rudnic.docxpriestmanmable
 
Kidney transplantation1408
Kidney transplantation1408Kidney transplantation1408
Kidney transplantation1408bondafairieal
 
Martha Anderson - USA - Monday 28 - Strategies to improve Tissue Donors
Martha Anderson -  USA - Monday 28 - Strategies to improve Tissue DonorsMartha Anderson -  USA - Monday 28 - Strategies to improve Tissue Donors
Martha Anderson - USA - Monday 28 - Strategies to improve Tissue Donorsincucai_isodp
 
Kidney Trafficking
Kidney TraffickingKidney Trafficking
Kidney Traffickingembledsoe
 
codi leggett and kelsey martin ethical debate
codi leggett and kelsey martin ethical debatecodi leggett and kelsey martin ethical debate
codi leggett and kelsey martin ethical debateCodi Leggett
 
Liver transplantation an update
Liver transplantation an updateLiver transplantation an update
Liver transplantation an updatemostafa hegazy
 
DTS2013_03_StateOfDonation_Nakagawa_101513.pptx
DTS2013_03_StateOfDonation_Nakagawa_101513.pptxDTS2013_03_StateOfDonation_Nakagawa_101513.pptx
DTS2013_03_StateOfDonation_Nakagawa_101513.pptxkiranpalepu5
 
POSTER TEMPLATE FOR HC DISPARITIES
POSTER TEMPLATE FOR HC DISPARITIESPOSTER TEMPLATE FOR HC DISPARITIES
POSTER TEMPLATE FOR HC DISPARITIESAshley York
 

Ähnlich wie Paired and Altruistic Kidney Donation In The UK (20)

2098
20982098
2098
 
Gabriel Danovitch - USA - Monday 28 - Alternatives to increase the number of...
Gabriel Danovitch - USA  - Monday 28 - Alternatives to increase the number of...Gabriel Danovitch - USA  - Monday 28 - Alternatives to increase the number of...
Gabriel Danovitch - USA - Monday 28 - Alternatives to increase the number of...
 
Intensive Care Professionals and their role in Organ Donation
Intensive Care Professionals and  their role in Organ DonationIntensive Care Professionals and  their role in Organ Donation
Intensive Care Professionals and their role in Organ Donation
 
Preliminary Research Data
Preliminary Research DataPreliminary Research Data
Preliminary Research Data
 
Faith and BAME on Organ Donation in UK
Faith and BAME  on Organ Donation in UKFaith and BAME  on Organ Donation in UK
Faith and BAME on Organ Donation in UK
 
Kidney Transplant Exploring Living Donation
Kidney Transplant Exploring Living DonationKidney Transplant Exploring Living Donation
Kidney Transplant Exploring Living Donation
 
10th Annual Utah's Health Services Research Conference - Assessment of Actual...
10th Annual Utah's Health Services Research Conference - Assessment of Actual...10th Annual Utah's Health Services Research Conference - Assessment of Actual...
10th Annual Utah's Health Services Research Conference - Assessment of Actual...
 
Marginal and extended criteria donors
Marginal and extended criteria donorsMarginal and extended criteria donors
Marginal and extended criteria donors
 
Donor assessment
Donor assessmentDonor assessment
Donor assessment
 
Marginal Donors/Expanded Criteria Donors Kidneys
Marginal Donors/Expanded Criteria Donors KidneysMarginal Donors/Expanded Criteria Donors Kidneys
Marginal Donors/Expanded Criteria Donors Kidneys
 
Anwar Naqvi Pakistan - Monday 28 - Management and organization models for d...
Anwar Naqvi   Pakistan - Monday 28 - Management and organization models for d...Anwar Naqvi   Pakistan - Monday 28 - Management and organization models for d...
Anwar Naqvi Pakistan - Monday 28 - Management and organization models for d...
 
Jonathan G Stine, Puja M Shah, Scott L Cornella, Sean R Rudnic.docx
Jonathan G Stine, Puja M Shah, Scott L Cornella, Sean R Rudnic.docxJonathan G Stine, Puja M Shah, Scott L Cornella, Sean R Rudnic.docx
Jonathan G Stine, Puja M Shah, Scott L Cornella, Sean R Rudnic.docx
 
Kidney transplantation1408
Kidney transplantation1408Kidney transplantation1408
Kidney transplantation1408
 
Renal Transplantation in S Asians
Renal Transplantation in S AsiansRenal Transplantation in S Asians
Renal Transplantation in S Asians
 
Martha Anderson - USA - Monday 28 - Strategies to improve Tissue Donors
Martha Anderson -  USA - Monday 28 - Strategies to improve Tissue DonorsMartha Anderson -  USA - Monday 28 - Strategies to improve Tissue Donors
Martha Anderson - USA - Monday 28 - Strategies to improve Tissue Donors
 
Kidney Trafficking
Kidney TraffickingKidney Trafficking
Kidney Trafficking
 
codi leggett and kelsey martin ethical debate
codi leggett and kelsey martin ethical debatecodi leggett and kelsey martin ethical debate
codi leggett and kelsey martin ethical debate
 
Liver transplantation an update
Liver transplantation an updateLiver transplantation an update
Liver transplantation an update
 
DTS2013_03_StateOfDonation_Nakagawa_101513.pptx
DTS2013_03_StateOfDonation_Nakagawa_101513.pptxDTS2013_03_StateOfDonation_Nakagawa_101513.pptx
DTS2013_03_StateOfDonation_Nakagawa_101513.pptx
 
POSTER TEMPLATE FOR HC DISPARITIES
POSTER TEMPLATE FOR HC DISPARITIESPOSTER TEMPLATE FOR HC DISPARITIES
POSTER TEMPLATE FOR HC DISPARITIES
 

Mehr von meducationdotnet

Mehr von meducationdotnet (20)

No Title
No TitleNo Title
No Title
 
Spondylarthropathy
SpondylarthropathySpondylarthropathy
Spondylarthropathy
 
Diagnosing Lung cancer
Diagnosing Lung cancerDiagnosing Lung cancer
Diagnosing Lung cancer
 
Eczema Herpeticum
Eczema HerpeticumEczema Herpeticum
Eczema Herpeticum
 
The Vagus Nerve
The Vagus NerveThe Vagus Nerve
The Vagus Nerve
 
Water and sanitation and their impact on health
Water and sanitation and their impact on healthWater and sanitation and their impact on health
Water and sanitation and their impact on health
 
The ethics of electives
The ethics of electivesThe ethics of electives
The ethics of electives
 
Intro to Global Health
Intro to Global HealthIntro to Global Health
Intro to Global Health
 
WTO and Health
WTO and HealthWTO and Health
WTO and Health
 
Globalisation and Health
Globalisation and HealthGlobalisation and Health
Globalisation and Health
 
Health Care Worker Migration
Health Care Worker MigrationHealth Care Worker Migration
Health Care Worker Migration
 
International Institutions
International InstitutionsInternational Institutions
International Institutions
 
Haemochromotosis brief overview
Haemochromotosis brief overviewHaemochromotosis brief overview
Haemochromotosis brief overview
 
Ascities overview
Ascities overviewAscities overview
Ascities overview
 
Overview of the Liver
Overview of the LiverOverview of the Liver
Overview of the Liver
 
Overview of Antidepressants
Overview of AntidepressantsOverview of Antidepressants
Overview of Antidepressants
 
Gout Presentation
Gout PresentationGout Presentation
Gout Presentation
 
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
 
Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?
 
Ophthamology Revision
Ophthamology RevisionOphthamology Revision
Ophthamology Revision
 

Paired and Altruistic Kidney Donation In The UK

  • 1. Paired and AltruisticPaired and Altruistic Kidney Donation InKidney Donation In The UKThe UK Deborah Green North Bristol Academy
  • 2. ObjectivesObjectives  Why this topic?  Paired donation  The process  UK programme and problems  Altruistic donation  Definition and development  Programmes worldwide  Patient views
  • 3. Kidney DonationKidney Donation  Types: DECEASED LIVE  Problems 1. ABO incompatibility 2. Presence of donor-specific HLA antibodies
  • 4. Paired DonationPaired Donation Scheme run by BTS and UKT since 2007 DONOR 1 RECIPIENT 1 DONOR 2 RECIPIENT 2
  • 5. The Matching ProcessThe Matching Process Quarterly matching runs Three stages: Identify all possible two-way exchanges Determine all combinations of exchange Identify optimum combinations
  • 6. Identifying Optimum Transplant NumberIdentifying Optimum Transplant Number Criteria Points Location of pairs •Same area - 20 •Otherwise - 0 HLA Match •Level 1 – 15 •Level 4 – 0 Sensitisation •0 – 50 points Donor – donor age difference •< 20 years – 3 points •> 20 years – 0 points Blood group matching •O donors reserved for O recipients
  • 7. UK Programme Jan 2007 – Jan 2011UK Programme Jan 2007 – Jan 2011 465 patients enrolled 198 transplants identified 51% of identified transplants have not taken place
  • 8. Outcome of Identified TransplantsOutcome of Identified Transplants 0 5 10 15 20 25 30 35 40 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Not proceeding Transplant No. of potential transplants Matching runApr 2007 Jan 2011 (Data from UKT)
  • 9. Non-Proceeding TransplantsNon-Proceeding Transplants Pos XM 38% Alternative transplant 20% Donor or recipient unfit 24% Other 18% (Data from UKT)
  • 10. ExplanationsExplanations Large proportion of highly sensitised patients in UK cohort ◦ 97% UK ◦ 41% The Netherlands (Johnson et al 2008) Blood type skewing ◦ 50% of pairs with blood type O recipients ◦ 30% of pairs with blood type O donors (15% match rate for O recipients currently) (Johnson et al 2008)
  • 11. SolutionsSolutions 1.Allowing compatible pairs to join the paired scheme • Simulation studies show up to 75% increase in match rate for O recipients (Gentry et al. 2007) 2.Combining desensitisation with paired donation • Complimentary modalities in the US for difficult to match patients. (Segev et al. 2008)
  • 12. Altruistic DonationAltruistic Donation Individual live donors with no genetic or personal link to a recipient. 60 altruistic donations in the UK to date
  • 13. Altruistic DonationAltruistic Donation 0 200 400 600 800 1000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Altruistic donor (non-directed) Paired exchange donor ABO incompatible donor HLA incompatible donor Unrelated donor (directed) Related donor (Data from UKT) Tx N◦ Year
  • 14. Where Do They Fit in?Where Do They Fit in? Donate to a recipient high on the deceased waiting list Donate to the paired donor scheme ◦ Transplant numbers increased 1.6 times per altruistic donor (Roodnat et al 2010)
  • 16. ReflectionReflection  Potential for the paired scheme to help many unmatched patients  Making best use of altruistic donors  MDT involvement at many levels  Impact on lives of patients
  • 17. What the patients say...What the patients say... ‘...I was on dialysis for 5 years before they finally found a match. I just wanted to die in my sleep...’ ‘ You feel so helpless. He was so ill and I wasnt able to do anything but wait...’ Any Questions?
  • 18. ReferencesReferences  Gentry SE, Montgomery RA, Segev DL. Kidney Paired Donation: Fundamentals, Limitations and Expansions. American Journal of Kidney Diseases. 2011; 57(1): 144-151  Johnson RJ, Allen JE, Fuggle SV, Bradley JA, Rudge C. Early Experience of Paired Living Kidney Donation In The UK. Transplantation. 2008; 86(12): 1672-1677  Mongomery RA, Renal Transplantation Across HLA and ABO Antibody Barriers: Integrated Paired Donation Into Desensitisation Protocols. American Journal of Transplantation. 2010; 10: 449-457  Rapaport FT. The case for a living emotionally related international kidney donor exchange registry. Transplant Proc. 1986; 18: 5  Kwak JY, Kwon OJ, Lee KS et al. Exchange-donor program in renal transplantation: A single centre experience. Transplant Proc. 1999; 31: 344  Johnson RJ et al. Paired and Altruistic Non-Directed Living Kidney Donation. Renal Transplant Services Meeting January 2011. Accessed March 2011  Segev DL, Kucirka LM, Gentry SF, Montgomery RA. Utilisation And Outcomes Of Kidney Paired Donation In the US. Transplantation. 2008; 86: 502-510  Gentry SE, Segev DL, Simmerling M, Mongomery RA. Expanding Kidney Paired Donation Through Participation By Compatible Pairs. American Journal of Transplantation. 2007; 7: 2361-2370  Gentry SE, Montgomery RA, Swihart BJ, Segev DL. The roles of dominos and never-ending altruistic donor chains in kidney paired donation. American Journal of Transplantation. 2009; 9: 1330-1336  The National Matching Scheme For Paired Donation. Available at www.bts.org.uk. Accessed March 2011  UK Transplant. Available at www.uktransplant.org.uk. Accessed February 2011

Hinweis der Redaktion

  1. LEGISLATION 2006 Lead to next slide – how is this done – Use ALGORITHMS
  2. Glasgow University
  3. Sensitisation = % of donors recipient is sensitised to in a pool of 10,000 donors HLA match = presence of HLA donor-specific antibodies leading to a positive crossmatch = high risk graft loss
  4. Possible reasons for this – NEXT SLIDE NICE guidance on eating disorders states ‘subclinical eating disorder MORE COMMON Groups who wouldnt usually be high risk for developing eating disorders have been shown to have increased risk – MALES and WOMEN &amp;gt;40 SO WHY DOES THIS HAPPEN....?
  5. Long term high BM readings = Long term complications – blood thicker = damage to small vessels Obvious from the next slides that this isnt a concern for some patients...
  6. Any party can withdraw at any point in the proceedings up to anaesthetisation Length of time for recovery Financial implications Psych referral pre and post Tx